<?xml version="1.0" encoding="UTF-8"?>
<ref id="B64-vaccines-07-00070">
 <label>64.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ciferri</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Chandramouli</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Leitner</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Donnarumma</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Cianfrocco</surname>
    <given-names>M.A.</given-names>
   </name>
   <name>
    <surname>Gerrein</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Friedrich</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Aggarwal</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Palladino</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Aebersold</surname>
    <given-names>R.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Antigenic characterization of the HCMV gH/gL/gO and pentamer entry complexes reveals binding sites for potently neutralizing human antibodies</article-title>
  <source>PLoS Pathog.</source>
  <year>2015</year>
  <volume>11</volume>
  <elocation-id>e1005230</elocation-id>
  <pub-id pub-id-type="doi">10.1371/journal.ppat.1005230</pub-id>
  <?supplied-pmid 26485028?>
  <pub-id pub-id-type="pmid">26485028</pub-id>
 </element-citation>
</ref>
